SABCS 2024: Optimizing early HER2 positive breast cancer treatment

The session took place at 4 p.m. on Tuesday, Dec. 10, 2024.
It was an Educational Session.

YOUTUBE CHAPTERS
0:00 Introduction by moderator Javier Cortés, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain
4:04 Gabe Sonke, Netherlands Cancer Institute, Amsterdam, Netherlands: "Neoadjuvant Management and Adaptive Strategies"
27:30 Adrienne G. Waks, Dana-Farber Cancer Institute, Boston, Massachusetts: "Treatment of Small HER2+ Tumors in Early-stage Setting"
53:15 Joyce O'Shaughnessy, Baylor-Sammons Cancer Center, Dallas, Texas: "HER2+ Early Breast Cancer Post-Neoadjuvant Management for non-pCR"
1:25:45 Beth Emory, Patient Advocate, The Woodlands, Texas
1:32:50 Q&A